Genetic predisposition of idiopathic pulmonary fibrosis

Current Opinion in Pulmonary Medicine

Volumn 3, Issue 5, 1997, Pages 336-340

  Mageto, Yolanda N ^a   Raghu, Ganesh ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL; DISEASE PREDISPOSITION; GENETICS; HUMAN; LUNG FIBROSIS; MIDDLE AGED; MOUSE; REVIEW;

ANIMALS; DISEASE SUSCEPTIBILITY; HUMANS; MICE; MIDDLE AGED; PULMONARY FIBROSIS;

EID: 0031225745     PISSN: 10705287     EISSN: None     Source Type: Journal    
DOI: 10.1097/00063198-199709000-00004     Document Type: Article

References (54)

1. Raghu G, Hert R: Interstitial lung diseases: genetic predisposition and inherited interstitial lung diseases. Semin Respir Med 1993, 14:323-332.
2. Crystal RG, Bitterman PB, Renaud SI, Hance JA, Keogh BA: Interstitial lung diseases of unknown cause: parts I and II. N Engl J Med 1984, 310:154-166, 235-244.
3. Respiratory Disease Task Force: Report of Problems, Research Approaches, Needs. Washington, DC: National Heart, Lung, and Blood Institute; 1972. [DHEW publication no. (NIH) 76-432.]
4. Division of Lung Disease, National Heart, Lung, and Blood Institute: Report of Task Force on Epidemiology of Respiratory Disease. Washington, DC: US Department of Health and Human Services; 1980. [NIH publication no. 81-2019.]
5. Coultas DB, Zumwalt RE, Black WC, Sobonya RE: The epidemiology of interstitial lung diseases. Am J Respir Crit Care Med 1994, 150:967-972.
6. Egan JJ, Stewart JP, Hasleton PS, Arrand JR, Carroll KB: Epstein-Barr virus replication within pulmonary epithelial cells in cryptogenic fibrosing alveolitis. Thorax 1995, 50:1234-1239.
7. Barbara JA, Hayashi S, Hegele RG, Hogg JC: Detection of Epstein-Barr virus in lymphocytic interstitial pneumonia by in situ hybridization. Am Rev Respir Dis 1992, 145:940-946.
8. Ueda T, Ohta K, Suzuku N, Yamaguchi M, Hirai K, Horiuchi T, Wantanabe J, Miyamoto T, Ito K: Idiopathic pulmonary fibrosis and high prevalence of serum antibodies to hepatitis C virus. Am Rev Respir Dis 1992, 146:266-268.
9. Irving WL, Day S, Johnston IDA: Idiopathic pulmonary fibrosis and hepatitis C virus infection. Am Rev Respir Dis 1993, 148:1683-1684.
10. Chapman JR, Charles PF, Venables PF, Thompson PJ, Haslam PL, Maini RN, Turner-Warick ME: Definition and clinical relevance of antibodies to nuclear ribonucleoprotein and other nuclear antigens in patients with cryptogenic fibrosing alveolitis. Am Rev Respir Dis 1984, 130:439-443.
11. Marshall RP, McAnulty RJ, Laurent GJ: The pathogenesis of pulmonary fibrosis: is there a fibrosis gene? Int J Biochem Cell Biol 1997, 29:P107-P120. A review of the literature addressing possible pathogenetic pathways and etiologies of pulmonary fibrosis. The article discusses available evidence to support the current hypotheses of genetic predisposition.
12. Rochester CL, Elias JA: Cytokines and cytokine networking in the pathogenesis of interstitial and fibrotic lung disorders. Sem Respir Med 1993, 14:389-416.
13. Kumar RK, Lykke AWJ: Messages and handshakes: cellular interaction in pulmonary fibrosis. Pathology 1995, 27:18-26.
14. Lazo JS, Hoyt DG: The molecular basis of interstitial pulmonary fibrosis caused by antineoplastic agents. Cancer Treat Rev 1990, 17:165-167.
15. Marinet Y, Rom WN, Grotendorst GR: Exaggerated spontaneous release of platelet-derived growth factor by alveolar macrophages from patients with idiopathic pulmonary fibrosis. N Engl J Med 1987, 317:202-209.
16. Raines EW, Bowen-Pope DF, Ross R: Platelet-derived growth factor. In Peptide Growth Factors and Their Receptors I. Edited by Sporn MB, Roberts AB. New York: Springer-Verlag; 1991:173-262.
17. Car BD, Meloni F, Luisetti M, Semenzato G, Gialdroni-Grassi G, Walz A: Elevated IL-8 and MCP-1 in the bronchoalveolar lavage fluid of patients with idiopathic pulmonary fibrosis and pulmonary sarcoidosis. Am J Respir Crit Care Med 1994, 149:655-659.
18. Montovani A, Sozzani S, Bottazzi B, Peri G, Sciacca FL, Locati M, Collotta F: Monocyte chemotactic protein-1 (MCP-1): signal transduction and involvement in the regulation of macrophage traffic in normal and neoplastic tissues. Adv Exp Med Biol 1993, 351:47-54.
19. Geddes DM, Webley M, Brewerton DA, Turton CW, Turner-Warick M, Murphy AH, Ward AM: Alpha-1 antitrypsin phenotypes in fibrosing alveolitis and rheumatoid arthritis. Lancet 1977, 2:1049-1051.
20. Michalski JP, McCombs CC, Scopelitis E, Biunodo JJ, Medsger TA Jr: Alpha-1-antitrypsin phenotypes including M subtypes in pulmonary disease associated with rheumatoid arthritis and systemic sclerosis. Arthritis Rheum 1986, 29:586-591.
21. Steers G, McMahan MJ, Greenan DM, Hillarby MC: Lack of association of the alpha-1-antitrypsin PIZ allele with rheumatoid arthritis or with its extra-articular complications. Dis Markers 1992, 10:151-157.
22. Varpela E, Tiilikainen A, Varpela M, Tukianen P: High prevalence of HLA-B15 and HLA-Dw6 inpatients with cryptogenic fibrosing alveolitis. Tissue Antigens 1979, 14:68-71.
23. Turton CWG, Morris LM, Lawler SD, Turner-Warick M: HLA in cryptogenic fibrosing alveolitis. Lancet 1978, 1:507-508.
24. Evans CC: HLA antigens in diffuse fibrosing alveolitis. Thorax 1976, 31:483.
25. Libby DM, Gibofsky A, Fotino M, Waters SJ, Smith JP: Immunogenic and clinical findings in idiopathic pulmonary fibrosis: association with B-cell alloantigen HLA-DR2. Am Rev Respir Dis 1983, 127:618-622.
26. Fulmar JD, Spovoska MS, von Gal ER, Crystal RG, Mittal KK: Distribution of HLA antigens in idiopathic pulmonary fibrosis. Am Rev Respir Dis 1978, 118:141-147.
27. Strimlan CV, Taswell HR, DeRemee RA, Kueppers F: HLA antigens and fibrosing alveolitis. Am Rev Respir Dis 1977, 116:1120.
28. Musk AW, Zilko PJ, Manners P, Kay PH, Kamboh MI: Genetic studies in familial fibrosing alveolitis: possible linkage with immunoglobulin allotypes (Gm). Chest 1986, 89:206-210.
29. McDevitt HO: Current concepts in Immunology: regulation of the immune response by the major histocompatibility system. N Engl J Med 1980, 303:1514-1517.
30. Watters LC: Genetic aspects of idiopathic pulmonary fibrosis and hypersensitivity pneumonitis. Semin Respir Med 1986, 7:317-325.
31. Ekimoto H, Takada K, Ohnuki T, Takahashi K, Matsuda A, Takita T, Umezawa H: Different sensitivity to bleomycin-induced pulmonary fibrosis among various strains of mice. J Clin Biochem Nutr 1987, 2:25-31.
32. Harrison JH, Lazo JS: Plasma and pulmonary pharmacokinetics of bleomycin in murine strains that are sensitive and resistant to bleomycin-induced pulmonary fibrosis. J Phar Exp Therapy 1988, 247:1052-1058.
33. Rubin E, Farber JL: The respiratory system. In Essential Pathology. Edited by Rubin E, Farber JL. Philadelphia: JB Lippincott; 1995:313-346.
34. Johnston CJ, Piedboeuf B, Baggs R, Rubin P, Finkelstein JN: Differences in correlation of mRNA gene expression in mice sensitive and resistant to radiation-induced pulmonary fibrosis. Rad Res 1995, 142:197-203.
35. Bhat M, Rojanasakul Y, Weber SL, Ma JY, Castranova V, Banks DE, Ma JK: Fluromicroscopic studies of bleomycin-induced intracellular oxidation in alveolar macrophages and its inhibition by taurine. Environ Health Perspect 1994, 102(suppl 10):91-96.
36. Duchesne GM: Fundamental basis of combined therapy in lung cancer: cell resistance to chemotherapy and radiotherapy. Lung Cancer 1994, 10(suppl 1):S67-S72.
37. Uchiyuma B, Mori Y, Sakai T, Yaekashiwa M, Abe T, Satoh K, Nukiwa T: Unexpectedly high incidence of idiopathic pulmonary fibrosis (IPF) among siblings of patients with IPF in Japan [abstract]. Am J Respir Crit Care Med 1995, 151:A689.
38. Sandoz E: Uber zwei Falle von fotaler Bronchektasle. Beitr Pathol Anat 1907, 41:495-516.
39. Hamman L, Rich AR: Acute diffuse interstitial fibrosis of the lungs. Bull Johns Hopkins Hosp 1944, 74:177-212.
40. Peabody JW, Peabody JW Jr, Hayes EW, Hayes EW Jr: Idiopathic pulmonary fibrosis: its occurrence in identical twin sisters. Dis Chest 1950, 18:330-334.
41. MacMillan JM: Familial pulmonary fibrosis. Dis Chest 1951, 20:426-436.
42. Adelman AG, Chertkow G, Hayton RC: Familial fibrocystic pulmonary dysplasia: a detailed family study. Can Med Assoc J 1966, 95:603-610.
43. Barzo P: Familial idiopathic fibrosing alveolitis. Eur J Respir Dis 1985, 66:350-352.
44. Bitterman PB, Rennard SI, Keogh BA, Wewers MD, Adelberg S, Crystal RG: Familial idiopathic pulmonary fibrosis: evidence of lung inflammation in unaffected family members. N Engl J Med 1986, 314:1343-1348.
45. Bonanni PP, Frymoyer JW, Jacox RA: Family study of idiopathic pulmonary fibrosis: a possible dysproteinemic and genetically determined disease. Am J Med 1965, 39:411-421.
46. Davies GM, Potts MW: Chronic diffuse interstitial pulmonary fibrosis in brothers. Guys Hosp Rep 1964, 113:36-44.
47. Donohue WL, Laski B, Uchida F, Munn JD: Familial fibrocystic pulmonary dysplasia and its relation to Hamman-Rich syndrome. Pediatrics 1959, 24:786-819.
48. Huges EW: Familial pulmonary fibrosis. Thorax 1964, 19:515-525.
49. Murphy A, O'Sullivan BJ: Familial fibrosing alveolitis. Ir J Med Sci 1981, 150:204-209.
50. Raghu G, Jarvic G, Lurton J, Schellenberg G, Wijsman E: Genetic study of idiopathic pulmonary fibrosis [abstract]. Am J Resp Crit Care Med 1996, 153:A405.
51. Solliday NH, Williams JA, Gaensler EA, Coutu RE, Carrington CB: Familial chronic interstitial pneumonia. Am Rev Respir Dis 1973, 108:193-204.
52. Swaye P, Van Ordstrand HS, McCormack LJ, Wolpaw SE: Familial Hamman-Rich syndrome. Dis Chest 1969, 20:426-436.
53. Javaheri S, Lederer DH, Pella JA, Mark GJ, Levine BW: Idiopathic pulmonary fibrosis in monozygotic twins: the importance of genetic predisposition. Chest 1980, 78:591-594.
54. Chuang PI, Rahgu G: Genetic predisposition in pulmonary disorders. Clin Pulm Med 1995, 2:359-367.